High Prescribing: A Case Study of High-Potency Medicinal Cannabis Inducing Psychosis.

Q4 Medicine Case Reports in Psychiatry Pub Date : 2024-12-07 eCollection Date: 2024-01-01 DOI:10.1155/crps/8870476
Richard C J Bradlow, Sophie Wright, Anamaria Szrajbman Vaz Da Silva, Ferghal Armstrong
{"title":"High Prescribing: A Case Study of High-Potency Medicinal Cannabis Inducing Psychosis.","authors":"Richard C J Bradlow, Sophie Wright, Anamaria Szrajbman Vaz Da Silva, Ferghal Armstrong","doi":"10.1155/crps/8870476","DOIUrl":null,"url":null,"abstract":"<p><p><b>Introduction:</b> There has been a recent significant increase in medical cannabis prescribing in Australia despite weak evidence for its effectiveness in treating the most common indications. Concern has been raised about the potential harms of inappropriate prescription of cannabis; however, there have been no prior published cases of psychosis secondary to medicinal cannabis in Australia. <b>Case Presentation:</b> We present a case of a 21-year-old Indigenous male with psychosis following switching from illicitly obtained cannabis to prescription cannabis, which resulted in Othello delusions towards his partner, violence towards her and ultimately an attempt to end his life. <b>Discussion:</b> Cannabis use is linked to the development of a psychotic illness whether it is prescribed or obtained illicitly. People who are prescribed cannabis are also at an elevated risk of developing cannabis use disorder (CUD). Cannabis prescribers need to screen for risk factors of drug-induced psychosis such as a family member with a psychotic illness, review patients regularly and provide harm minimisation advice to prevent damage from their prescription. <b>Conclusion:</b> There are clear dangers to overprescribing medicinal cannabis and the care that needs to be taken by prescribers to avoid them. There is a need for a change in the regulation of cannabis prescribing in Australia. Further research is warranted on the effects of the increase in prevalence of cannabis prescribing.</p>","PeriodicalId":9631,"journal":{"name":"Case Reports in Psychiatry","volume":"2024 ","pages":"8870476"},"PeriodicalIF":0.0000,"publicationDate":"2024-12-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11646144/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Case Reports in Psychiatry","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/crps/8870476","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: There has been a recent significant increase in medical cannabis prescribing in Australia despite weak evidence for its effectiveness in treating the most common indications. Concern has been raised about the potential harms of inappropriate prescription of cannabis; however, there have been no prior published cases of psychosis secondary to medicinal cannabis in Australia. Case Presentation: We present a case of a 21-year-old Indigenous male with psychosis following switching from illicitly obtained cannabis to prescription cannabis, which resulted in Othello delusions towards his partner, violence towards her and ultimately an attempt to end his life. Discussion: Cannabis use is linked to the development of a psychotic illness whether it is prescribed or obtained illicitly. People who are prescribed cannabis are also at an elevated risk of developing cannabis use disorder (CUD). Cannabis prescribers need to screen for risk factors of drug-induced psychosis such as a family member with a psychotic illness, review patients regularly and provide harm minimisation advice to prevent damage from their prescription. Conclusion: There are clear dangers to overprescribing medicinal cannabis and the care that needs to be taken by prescribers to avoid them. There is a need for a change in the regulation of cannabis prescribing in Australia. Further research is warranted on the effects of the increase in prevalence of cannabis prescribing.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
高处方:强效药用大麻诱发精神病个案研究。
导言:尽管医用大麻在治疗最常见适应症方面的有效性证据不足,但最近澳大利亚的医用大麻处方量仍大幅增加。人们对不适当的大麻处方可能造成的危害表示担忧;然而,在澳大利亚,此前尚未有因服用药用大麻而继发精神病的公开病例。病例介绍:我们介绍了一个 21 岁土著男性的病例,他在从非法获得的大麻转为处方大麻后出现了精神病,导致他对伴侣产生黑白棋妄想、对她施暴并最终试图结束自己的生命。讨论:无论是处方大麻还是非法获得的大麻,其使用都与精神病的发展有关。被开具大麻处方的人患上大麻使用障碍(CUD)的风险也很高。大麻处方医生需要筛查药物诱发精神病的风险因素,如家庭成员患有精神病,定期复查患者,并提供危害最小化建议,以防止处方造成损害。结论过量开具药用大麻处方有明显的危险,处方者需要注意避免这些危险。澳大利亚有必要改变对大麻处方的监管。有必要对大麻处方增加的影响进行进一步研究。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Case Reports in Psychiatry
Case Reports in Psychiatry Medicine-Psychiatry and Mental Health
CiteScore
1.00
自引率
0.00%
发文量
49
审稿时长
12 weeks
期刊最新文献
High Prescribing: A Case Study of High-Potency Medicinal Cannabis Inducing Psychosis. Doxazosin Immediate Release as a Novel Treatment for Nightmares in Posttraumatic Stress Disorder. Tolerance of Bupropion SR After Delayed-Onset Urticaria and Angioedema Associated With Bupropion XL. Delusional Parasitosis in Comorbidity With Shared Paranoid Disorder in a Marriage. A Boy With KIF11-Associated Disorder Along With ADHD and ASD: Collaboration Between Paediatrics and Child Psychiatry.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1